tiprankstipranks
iTeos Therapeutics (ITOS)
NASDAQ:ITOS
US Market
Holding ITOS?
Track your performance easily

iTeos Therapeutics (ITOS) Stock Investors

175 Followers
Based on 769,002 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ITOS
On average, investors allocate 0.00% of their portfolios to ITOS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 769,002 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ITOS

3.4%
Last 7
Days
1.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ITOS, out of 769,002 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ITOS Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,691 investors who made their portfolios public
The table shows changes in ITOS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ITOS Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Enphase Energy
4.56%
-0.05%
+0.53%
8.59B
Technology
Li Auto
5.56%
-2.10%
-4.97%
22.65B
Consumer Cyclical
Viking Therapeutics
4.53%
-0.20%
+7.08%
5.75B
Healthcare
Block
4.40%
-0.22%
+2.93%
57.46B
Technology
DraftKings
5.48%
-1.70%
+0.74%
38.35B
Consumer Cyclical
Plug Power
5.22%
-1.27%
-1.21%
1.72B
Industrials
Merck & Company
3.40%
-0.65%
+3.87%
252.61B
Healthcare
Riot Platforms
5.28%
+0.31%
+2.49%
3.91B
Financial
Bristol-Myers Squibb
3.55%
-0.55%
-1.06%
118.10B
Healthcare
CVS Health
3.99%
-1.41%
-0.90%
71.86B
Healthcare
Based on the activity of 769,002 active portfolios
Open your Smart Portfolio

ITOS Investor Analysis

ITOS investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.1%
of ITOS holders
are under 35
Average Segment Performance
Average P/E Ratio29.47
Beta10.82
Dividend Yield99.38%
ITOS investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
52.8%
of ITOS holders
are between 35–55
Average Segment Performance
Average P/E Ratio26.86
Beta20.87
Dividend Yield46.37%
ITOS investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
36.1%
of ITOS holders
are over 55
Average Segment Performance
Average P/E Ratio25.26
Beta9.51
Dividend Yield77.60%
Overview of age group and performance of ITOS stock investors
See who invests in ITOS according to age group and performance.

FAQ

How many retail Investors hold ITOS?
<0.1% of TipRanks' retail investors hold ITOS in their portfolios.
    What is ITOS Investor Sentiment?
    ITOS’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of ITOS in the last 7 days?
      ▲ 3.4% of TipRanks' retail investors changed their holding of ITOS in the last 7 days.
        What percentage of retail investors changed their holding of ITOS in the last 30 days?
        ▼ 1.1% of TipRanks' retail investors changed their holding of ITOS in the last 30 days.
          What is the average age of retail investors who hold ITOS?
          The average age of ITOS Holders is between 35–55.
            What other stocks have ITOS investors also bought?
            ITOS Investors also bought ENPH, LI, VKTX, SQ, DKNG, PLUG, MRK, RIOT, BMY, CVS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              CNCCentene
              CORTCorcept Therapeutics
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis